Risk for Permanent Pacemaker After Transcatheter Aortic Valve Implantation: A Comprehensive Analysis of the Literature
Top Cited Papers
- 3 November 2011
- journal article
- review article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 23 (4), 391-397
- https://doi.org/10.1111/j.1540-8167.2011.02211.x
Abstract
Permanent pacemaker (PM) requirement is a known complication after transcatheter aortic valve implantation (TAVI). There are, however, no systematic data concerning this complication. To determine the incidence and potential predictors of permanent PM requirement after TAVI based on published literature. We conducted a MEDLINE search to identify potentially relevant literature dealing with PM requirement after TAVI. Data were collected on paper extraction forms by 2 independent investigators. There were 32 relevant published studies comprising data of 5,258 patients without an implanted PM before TAVI. An Edwards-Sapiens® prosthesis (ESP) was implanted in 2,887 patients, whereas 2,371 patients received a CoreValve® prosthesis (CVP). The crude incidence of PM implantation after TAVI was 15%. Six hundred and fourteen of 2,371 (25.8%) CVP patients and 189 of the 2,887 (6.5%) ESP patients had to receive a permanent PM (odds ratio [OR] 4.91, 95% confidence interval [CI] 4.12-5.86, P < 0.001). Presence of right bundle branch block (RBBB) before TAVI was a significant predictor for development of complete atrioventricular (AV) block and subsequent PM need (OR 1.358, 95% CI 1.001-1.841, P = 0.02). More than 90% of all AV-block requiring PM implantation occurred immediately or within 7 days after TAVI. Patients undergoing TAVI with implantation of CVP are at significantly higher risk for development of AV block and subsequent need for permanent PM, particularly if RBBB preexists. Since AV block occurs in >90% within the first week after the procedure, careful monitoring should be performed for at least 7 days after TAVI.Keywords
This publication has 41 references indexed in Scilit:
- Early and Late (One Year) Outcomes Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis (from the United States REVIVAL Trial)The American Journal of Cardiology, 2011
- Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve ImplantationThe American Journal of Cardiology, 2011
- Transapical Versus Transfemoral Aortic Valve Implantation: A Comparison of Survival and SafetyThe Annals of Thoracic Surgery, 2011
- Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosisAmerican Heart Journal, 2010
- Usefulness of Percutaneous Aortic Valve Implantation to Improve Quality of Life in Patients >80 Years of AgeThe American Journal of Cardiology, 2010
- Incidence and Predictors of Atrioventricular Conduction Impairment After Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2010
- Transcatheter aortic valve implantation for severe aortic stenosis—a new paradigm for multidisciplinary intervention: A prospective cohort studyAmerican Heart Journal, 2010
- ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Acute Predictors of Subacute Complete Heart Block After Alcohol Septal Ablation for Obstructive Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986